Augustina Isioma Ikusemoro: Why Plasma and RBC Transfusions Follow Different Compatibility Rules
Augustina Isioma Ikusemoro, Hematology and Transfusion Medicine Specialist at Sharjah Blood Transfusion and Research Center, shared a post on LinkedIn:
“The wrong blood product can turn a life-saving transfusion into a life-threatening mistake.
ABO compatibility is not just laboratory science – it is patient safety.
One of the most misunderstood areas in transfusion medicine is this:
RBC compatibility and plasma compatibility are not the same.
For Red Blood Cells (RBCs):
We avoid giving antigens the patient does not have.
- Group O – universal RBC donor
- Group AB – universal RBC recipient
But for Plasma (FFP):
The rule is reversed.
- Group AB plasma – universal plasma donor
- Group O patients – can receive plasma from all groups
And what happens in emergencies when AB plasma is unavailable for an AB patient?
Clinical judgment matters.
Low-titer Group A plasma may be the preferred alternative.
Low-titer Group O plasma may be used as a last resort.
Group B plasma should generally be avoided.
The key lesson?
Knowing compatibility saves lives.
Because in transfusion medicine:
Right patient. Right product. Right time.
Not all blood products follow the same compatibility rules – and understanding the difference can prevent avoidable transfusion reactions.
Signature of Blood Doki. Educate. Empower. Elevate. Better blood. Better care. Better outcomes.”
Other posts featuring Augustina Isioma Ikusemoro on Hemostasis Today.
-
May 22, 2026, 13:08Anas Hamad: Thrombosis as Overlooked Clinical Challenge in APL
-
May 22, 2026, 12:29Neema Ngugi: Highlighting 6 Major Types of Anemia
-
May 22, 2026, 12:27Jacinto López Sagaseta: Solving the Structural Puzzle of FVIIa–EPCR Interaction
-
May 22, 2026, 12:25Shehab Mohamed: Exploring the Emerging Link Between JAK2 Mutations and Thoracic Aortic Aneurysms
-
May 22, 2026, 11:52Prakash W. Kamat: Highlighting the Role of Physical Activity in Hemophilia Management
-
May 22, 2026, 11:43Mohamed Hanafy Morsy: Understanding Hemochromatosis – Genetics Made Simple
-
May 22, 2026, 10:23Rucha Patil: Insights from The National Haemophilia Conclave 2026
-
May 22, 2026, 10:11Narat Srivali: New Systematic Review and Meta-Analysis on Glucocorticoid Therapy and The Risk of VTE
-
May 22, 2026, 10:02Greta Mulders: Nursing Leadership in Haemophilia Gene Therapy